Cargando…
Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014504/ https://www.ncbi.nlm.nih.gov/pubmed/33792668 http://dx.doi.org/10.1093/eurheartj/ehab092 |
| _version_ | 1783673561883344896 |
|---|---|
| author | Marx, Nikolaus Floege, Jürgen |
| author_facet | Marx, Nikolaus Floege, Jürgen |
| author_sort | Marx, Nikolaus |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8014504 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80145042021-04-07 Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial Marx, Nikolaus Floege, Jürgen Eur Heart J Clnical Research Oxford University Press 2021-04-01 /pmc/articles/PMC8014504/ /pubmed/33792668 http://dx.doi.org/10.1093/eurheartj/ehab092 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Clnical Research Marx, Nikolaus Floege, Jürgen Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial |
| title | Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial |
| title_full | Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial |
| title_fullStr | Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial |
| title_full_unstemmed | Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial |
| title_short | Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial |
| title_sort | dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the dapa-ckd trial |
| topic | Clnical Research |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014504/ https://www.ncbi.nlm.nih.gov/pubmed/33792668 http://dx.doi.org/10.1093/eurheartj/ehab092 |
| work_keys_str_mv | AT marxnikolaus dapagliflozinadvancedchronickidneydiseaseandmortalitynewinsightsfromthedapackdtrial AT floegejurgen dapagliflozinadvancedchronickidneydiseaseandmortalitynewinsightsfromthedapackdtrial |